You Don’t Have to Snore

Why It Matters

Snoring and untreated apnea drive cardiovascular disease and productivity losses, making scalable, low‑cost therapies a priority for insurers and employers.

Key Takeaways

• One in four adults snore regularly, many have apnea
• CPAP adherence drops below 60% due to discomfort
• Myofunctional therapy can halve snoring in weeks
• Phone‑based exercise apps lower barriers to therapy
• Modern diet and oral development fuel snoring epidemic

Pulse Analysis

Snoring is no longer a harmless nuisance; it is a symptom of obstructive sleep apnea that afflicts up to half of chronic snorers and contributes to hypertension, diabetes, and cardiovascular events. Demographic shifts—longer lifespans, higher body‑mass indices, and softer modern diets—have altered airway anatomy, creating a perfect storm for airway collapse during sleep. As the prevalence of sleep‑related breathing disorders climbs, employers and health plans face rising costs from reduced daytime productivity and increased medical claims.

The treatment landscape remains fragmented. Continuous‑positive‑airway‑pressure (CPAP) machines deliver the most reliable physiological correction but suffer from low patient adherence because of bulk and discomfort. Custom mandibular‑advancement devices offer a discreet alternative but can be pricey and require dental expertise. In recent years, orofacial myofunctional therapy has emerged, backed by randomized trials showing significant reductions in snoring intensity and apnea‑hypopnea indices. Researchers attribute success to strengthened tongue and pharyngeal muscles, which maintain airway patency without external pressure.

Digital health platforms are accelerating adoption of myofunctional therapy. Apps such as Airway Gym translate clinically validated exercises into short, phone‑based sessions, enabling users to train anywhere. While early adopters report rapid improvements, sustained engagement remains a challenge; the regimen demands daily, multi‑second bursts that compete with other health habits. Nonetheless, the low cost, scalability, and growing evidence base position exercise‑driven solutions as a disruptive force, prompting insurers to consider coverage and manufacturers to develop integrated wearables that monitor compliance and outcomes.